Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial

Antiandrogens have demonstrated a protective effect for COVOD-19 patients in observational and interventional studies. The goal of this study was to determine if proxalutamide, an androgen receptor antagonist, could be an effective treatment for men with COVID-19 in an outpatient setting. A randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales: McCoy, John, Goren, Andy, Cadegiani, Flávio Adsuara, Vaño-Galván, Sergio, Kovacevic, Maja, Situm, Mirna, Shapiro, Jerry, Sinclair, Rodney, Tosti, Antonella, Stanimirovic, Andrija, Fonseca, Daniel, Dorner, Edinete, Onety, Dirce Costa, Zimerman, Ricardo Ariel, Wambier, Carlos Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326462/
https://www.ncbi.nlm.nih.gov/pubmed/34350193
http://dx.doi.org/10.3389/fmed.2021.668698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326462/
https://www.ncbi.nlm.nih.gov/pubmed/34350193
http://dx.doi.org/10.3389/fmed.2021.668698

Ejemplares similares